Ute Jentsch

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

Sheena McCormack, Gita Ramjee, Anatoli Kamali et al. · The Lancet · 2010 · 334 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +14

Antibodies against Human Herpesvirus 8 in Black South African Patients with Cancer

Freddy Sitas, Henri Carrara, Valerie Beral et al. · New England Journal of Medicine · 1999 · 272 citations · Full text

Life Sciences, Infectious Diseases, Oncology +10

The spectrum of HIV-1 related cancers in South Africa

Freddy Sitas, Rosana Pacella, Henri Carrara et al. · International Journal of Cancer · 2000 · 166 citations

Medicine, Infectious Diseases, Oncology +13

Evaluation of Two Line Probe Assays for Rapid Detection of Mycobacterium tuberculosis, Tuberculosis (TB) Drug Resistance, and Non-TB Mycobacteria in HIV-Infected Individuals with Suspected TB

Anne F. Luetkemeyer, Michelle A. Kendall, Xingye Wu et al. · Journal of Clinical Microbiology · 2014 · 59 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population

Sinead Delany‐Moretlwe, Ute Jentsch, Helen A. Weiss et al. · Sexually Transmitted Infections · 2009 · 55 citations

Veterinary Medicine, Infectious Diseases, Diagnostic Microbiology +15